Literature DB >> 12190863

Interferon-gamma, a strong suppressor of cell proliferation, induces upregulation of keratin K6, one of the inflammatory- and proliferation-associated keratins.

Naoko Hattori1, Mayumi Komine, Shoichiro Yano, Takehiko Kaneko, Yasushi Hanakawa, Koji Hashimoto, Kunihiko Tamaki.   

Abstract

Keratin K6 is known as an inflammatory and hyperproliferative keratin, and is induced by an inflammatory and hyperproliferative agent. In this study, we demonstrated that interferon-gamma, an antiproliferative agent, also induces keratin K6. We used normal human ex vivo skin, normal human cultured keratinocytes, HaCaT keratinocytes, and DJM cells to examine the induction of K6 by interferon-gamma, by immunohistochemical staining, Western blot analysis, promoter chloramphenicol acetyl transferase assay, and reverse transcriptase polymerase chain reaction of mRNA. We succeeded in demonstrating the induction of keratin K6 by interferon-gamma in ex vivo human skin and HaCaT keratinocytes at the protein and message level, and in cultured normal human keratinocytes at the promoter level. The inhibition of the signal transducing activator of transcription 1 pathway by a dominant-negative transfer gene caused the inhibition of K6 induction by interferon-gamma, and the blocking of nuclear factor kappaB using antisense oligonucleotides also inhibited the K6 induction. We also blocked the released interleukin-1alpha from keratinocytes after stimulation with interferon-gamma by neutralizing antibodies, which showed a decrease in the K6 induction. Our results suggest that a small amount of interleukin-1alpha, which cannot induce K6 by itself, is secreted upon stimulation by interferon-gamma, and that the induction of K6 occurs through the synergistic effect of the interferon-gamma/signal transducing activator of transcription 1 and interleukin-1alpha/nuclear factor kappaB pathways. This is the first report to describe K6 induction in epidermal keratinocytes by interferon-gamma and indicate a probable signal transduction pathway, and demonstrates that K6 is a possible partner of K17 in the inflammatory process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12190863     DOI: 10.1046/j.1523-1747.2002.01843.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  5 in total

1.  Differential regulation of surface receptor expression, proliferation, and apoptosis in HaCaT cells stimulated with interferon-γ, interleukin-4, tumor necrosis factor-α, or muramyl dipeptide.

Authors:  Emale El Darzi; Samer Bazzi; Sarah Daoud; Karim S Echtay; Georges M Bahr
Journal:  Int J Immunopathol Pharmacol       Date:  2017-04-28       Impact factor: 3.219

2.  Detrimental Effects of IFN-γ on an Epidermolysis Bullosa Simplex Cell Model and Protection by a Humanized Anti-IFN-γ Monoclonal Antibody.

Authors:  Cedric Badowski; Tong San Tan; Teimur Aliev; David Trudil; Maria Larina; Viсtoria Argentova; Muhammad Jasrie Firdaus; Paula Benny; Vivien S T Woo; E Birgitte Lane
Journal:  JID Innov       Date:  2022-01-13

3.  Identification of Keratinocyte Mitogens: Implications for Hyperproliferation in Psoriasis and Atopic Dermatitis.

Authors:  Hanna Niehues; Gijs Rikken; Ivonne M J J van Vlijmen-Willems; Diana Rodijk-Olthuis; Piet E J van Erp; Patrick L J M Zeeuwen; Joost Schalkwijk; Ellen H van den Bogaard
Journal:  JID Innov       Date:  2021-10-22

4.  CD147 mediates epidermal malignant transformation through the RSK2/AP-1 pathway.

Authors:  Xu Zhang; Yeye Guo; Ta Xiao; Jie Li; Aiyuan Guo; Li Lei; Chong Jin; Qi Long; Juan Su; Mingzhu Yin; Hong Liu; Chao Chen; Zhe Zhou; Susi Zhu; Juan Tao; Shuo Hu; Xiang Chen; Cong Peng
Journal:  J Exp Clin Cancer Res       Date:  2022-08-13

5.  Human skin culture as an ex vivo model for assessing the fibrotic effects of insulin-like growth factor binding proteins.

Authors:  Hidekata Yasuoka; Adriana T Larregina; Yukie Yamaguchi; Carol A Feghali-Bostwick
Journal:  Open Rheumatol J       Date:  2008-03-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.